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It is widely accepted that oxidative stress plays an important role in the pathophysiology of male infertility and that antioxidants 
could have a significant role in the treatment of male infertility. The main objectives of this study are: 1) to systematically review 
the current evidence for the utility of antioxidants in the treatment of male infertility; and 2) propose evidence-based clinical 
guidelines for the use of antioxidants in the treatment of male infertility. A systematic review of the available clinical evidence was 
performed, with articles published on Scopus being manually screened. Data extracted included the type of antioxidant used, 
the clinical conditions under investigation, the evaluation of semen parameters and reproductive outcomes. The adherence to the 
Cambridge Quality Checklist, Cochrane Risk of Bias for randomized controlled trials (RCTs), CONSORT guidelines and JADAD 
score were analyzed for each included study. Further, we provided a Strength Weakness Opportunity Threat (SWOT) analysis to 
analyze the current and future value of antioxidants in male infertility. Of the 1,978 articles identified, 97 articles were included 
in the study. Of these, 52 (53.6%) were uncontrolled (open label), 12 (12.4%) unblinded RCTs, and 33 (34.0%) blinded RCTs, 
whereas 44 (45.4%) articles tested individual antioxidants, 31 (32.0%) a combination of several products in variable dosages, and 
22 (22.6%) registered antioxidant products. Based on the published evidence, we 1) critically examined the necessity of addi-
tional double-blind, randomized, placebo-controlled trials, and 2) proposed updated evidence-based clinical guidelines for anti-
oxidant therapy in male infertility. The current systematic review on antioxidants and male infertility clearly shows that antioxidant 
supplementation improves semen parameters. In addition, it provides the indications for antioxidant treatment in specific clinical 
conditions, including varicocele, unexplained and idiopathic male infertility, as well as in cases of altered semen quality.
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Infertility affects approximately 15% of couples glo­
bally, with 2.5%–12% believed to be solely due to male 
factors. The incidence of male factor infertility varies 
according to the geographical location, ranging from 
20% to 70% [1]. The causes of male infertility are diverse, 
including genetic causes, varicocele, reproductive tract 
infections, obstructive or non­obstructive azoospermia, 
male hypogonadism, and anti­sperm antibodies. How­
ever, a large proportion of cases remain unexplained 
(unexplained male infertility, UMI) (±15%) or idiopathic 
(idiopathic male infertility, IMI) (30%–50%) in the ab­
sence of identifiable female factors [2,3]. In addition, 
numerous environmental and lifestyle factors have been 
associated with poor reproductive outcomes in males [4]. 
Importantly, oxidative stress has been established as a 
significant mediator in many known causes and risk 
factors of male infertility, and has further been associ­
ated with 30% to 80% of IMI cases in a condition termed 
male oxidative stress infertility (MOSI) [2,5]. Therefore, 
the use of antioxidants to reduce oxidative stress across 
a range of etiologies and risk factors of male infertility 
has gained increasing attention. This is supported by the 
wide availability of oral antioxidants, excellent safety 
and bioavailability profiles, and that antioxidants are 
considered relatively cost effective [5,6]. Therefore, there 
is a growing trend of prescribing antioxidants to all 
males with infertility, even without complete evaluation 
or relevant guidelines [7].
Exogenous administration of antioxidants has been 
explored for decades, and the effects of several antioxi­
dants on male fertility have been extensively reported. 
Numerous trials of different qualities using various 
antioxidants as mono­ or poly­formulations, which may 
include pharmacologically­active herbal extracts, have 
been reported [8­11]. The topic was first summarized 
by a Cochrane meta­analysis in 2011, with updated 
reviews in 2014 and 2019 [8,9,11]. These reviews inves­
tigated the therapeutic benefit of male antioxidant 
treatment for couples undergoing assisted reproduc­
tive technology (ART). Based on limited randomized 
controlled trials (RCTs), the reviews concluded that low 
level evidence supports antioxidant therapy in infer­
tile males to increase pregnancy and live birth rates, 
with no evidence for increased risk of miscarriage 
[8,9,11]. Majzoub and Agarwal (2018) [10] conducted a 
systematic review on antioxidant treatment in infer­
tile men, concluding that antioxidants have a positive 
effect on male fertility, including semen parameters 
and advanced sperm function, ART outcomes and live 
birth rates. Antioxidants that are commonly used clini­
cally and investigated scientifically as either an indi­
vidual application or in combination include vitamin 
A, vitamin C, vitamin E, carnitine, N­acetyl cysteine, 
coenzyme Q10 and lycopene, along with important 
antioxidant co­factors zinc, selenium, and folic acid, as 
these compounds are significantly involved in essential 
sperm functions (Fig. 1) [12­15]. However, the outcomes 
of clinical trials included in the systematic reviews are 
not consistent, ranging from clear benefit to no clinical 
effect of the treatment, or even having significant de­
trimental effects [16­20]. The reasons for this inconsis­
tency are multifactorial and include: small numbers of 
participants in the studies, variable treatment regimens, 
dosages, treatment duration, and the lack of placebo­
controlled studies. In addition, many of the trials did not 
evaluate final reproductive outcomes, such as live birth 
rate, but only certain specific aspects such as seminal 
volume, sperm concentration and motility, morpho­
logy, seminal levels of reactive oxygen species (ROS) or 































































Fig. 1.  Individual antioxidant com-
pounds that have significant effects on 
sperm functions. CoQ: coenzyme Q.
Ashok Agarwal, et al: Antioxidant Therapy in Male Infertility
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often given in non­proven dosages, thus neglecting the 
fine bodily redox balance that is necessary for normal 
physiology, including reproductive functions [21]. If the 
dosage is too low, the treatment might be ineffective; if 
it is too high, it can result in an excess of antioxidants 
causing ‘reductive stress’, which is as detrimental as 
oxidative stress [22,23]. Reductive stress due to inappro­
priate antioxidant dosage may lead to infertility [23,24]. 
In this regard, high dosages of vitamin E have been 
shown to have adverse effects [20]. Recently more ba­
lanced antioxidant formulations have shown promising 
results whereby seminal oxidative stress was reduced, 
sperm function improved and pregnancies achieved 
[25,26].
With the current rationale and increased use of anti­
oxidants to counteract male infertility, and the hetero­
geneous and inconsistent data currently available, this 
study aims to: 1) systematically review the current evi­
dence for antioxidant use to ameliorate male infertility; 
and 2) propose updated evidence­based clinical guide­
lines for the use of antioxidants in male infertility.
MATERIALS AND METHODS
1. Literature search strategy
In order to support the development of  clinical 
guidelines for antioxidant use in male infertility, a sys­
tematic review of the available clinical evidence was 
performed to systematically identify relevant clinical 
trials investigating the impact of antioxidant therapy 
on semen quality. A literature search was performed 
according to the Preferred Reporting Items for System­
atic Reviews and Meta­Analyses (PRISMA) guidelines 
[27]. The Scopus database was chosen as it currently in­
cludes over 1.4 billion cited references, with over 70,000 
indexed articles (https://www.elsevier.com/solutions/
scopus/how­scopus­works/content). The search was con­
ducted on July 15th, 2020 to identify studies investi­
gating the use of antioxidants in the treatment of male 
infertility, with no restriction on publication date.
The following keyword strings and Boolean Opera­
tors were used: TITLE­ABS­KEY (“antioxidant*”) 
AND TITLE­ABS­KEY (“male infertil*” OR “infertile 
male*” OR “infertile men” OR “male subfertil*” OR 
“male steril*” OR “sperm*” OR “seminal” OR “semen”). 
Further specifications of the search are presented in 
Supplementary Table 1. Automatic filters were used in 
the database to specifically include only English origi­
nal articles and exclude other types of publication such 
as book chapters, conference papers, editorials, notes, 
letters, short surveys, erratum, and books.
The articles identified through the keyword search 
were subsequently screened manually by title, key­
words and abstract for eligibility. This screening was 
independently done by three researchers (RF; KL; 
MKPS), and the number of articles excluded through 
screening was recorded. Full text articles were then 
reviewed for eligibility using the inclusion and exclu­
sion criteria provided in Table 1 , and the number of 
articles excluded based on these criteria was recorded.
Data was subsequently extracted from the eligible 
articles, including the clinical trial design, the type of 
antioxidant or antioxidant formulation used, the clini­
cal condition under investigation, the evaluation of se­
men parameters and/or sperm function tests (i.e., sperm 
DNA fragmentation [SDF], oxidative stress markers, 
capacitation/acrosome reaction, and zona binding test) 
as well as reproductive outcomes (i.e., fertilization, 
implantation, pregnancy, miscarriage, and live birth 
rates).
2. Evaluation of study quality
The quality of all studies included was evaluated by 
applying the Cambridge Quality Checklist [28]. More­
Table 1. Proposed inclusion and exclusion for article selection
Inclusion Exclusion
Human participants Animal and in vitro studies
Antioxidants used as intervention individually or combined Intervention not clearly reported as an antioxidant
Open or controlled clinical trials Abstracts only, conference abstracts, book chapters, case series, 
review articles
At least one semen parameter (sperm concentration, motility, mor-
phology) and/or sperm function parameters (sperm DNA fragmen-
tation, seminal oxidative stress markers, mitochondrial membrane 




over, the quality of RCT was further evaluated by 
using the Cochrane Risk of Bias [29] and the JADAD 
score [30], as well as by evaluating the adherence to 
CONSORT guidelines [31]. Based on a combination of 
these quality evaluation tools, the studies were catego­
rized into “low” (0) and “high” (1) quality. All uncon­
trolled studies were considered “low­quality”, in com­
parison with controlled studies, which were evaluated 
according to the criteria reported in Supplementary 
Table 2. We have created this scoring system, as no 
such method was previously reported in the literature.
In addition, the most recent clinical trials reporting 
the effect of antioxidant treatment on male infertility, 
published from January 2019 to July 2020, were further 
ranked based on study design, the sample size analysed, 
the inclusion/exclusion criteria used for selecting the 
population, the antioxidant regimen used, the length 
of treatment, the assessment of oxidative stress mark­
ers, pregnancy and live birth rates. This range of time 
was specifically selected to gain an understanding of 
the most recent evidence on the antioxidant therapy 
and the quality of the studies currently conducted. The 
selection of these criteria was achieved through a con­
sensus among the male infertility experts involved in 
this study. The system provides a total score of a maxi­
mum of 12 points and a classification of the articles 
in “low” (<6 points) and “high” (≥6 points) quality, as 
reported in Supplementary Table 3.
Clinical recommendations were proposed based on 
the quality of the evidence, classified as A, B, C, D 
(Oxford Centre for Evidence­Based Medicine 2011 





Statistical analysis was performed using MedCalc 
statistical software version 19.5.3. (MedCalc Software 
bv, Ostend, Belgium). Chi­square test was used to eval­
uate the association between the quality of the study 
and the outcomes (positive or no/negative effect) due 
to antioxidant treatment on semen parameters and 
sperm function such as oxidative stress and SDF are 
presented in Table 2 [25,26,32­121]. A p­value <0.05 was 
considered statistically significant. When the p­value 
was ≥0.05, a sample size calculation was carried out to 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A total number of  1,978 articles were identified 
through the application of the keyword search strat­
egy. Through manual screening of the title, keywords 
and abstract, non­relevant articles (n=1,864) were ex­
cluded (Fig. 2).
Following full­text review for eligibility using the in­
clusion and exclusion criteria, 17 articles were further 
excluded, resulting in 97 articles that were eligible for 
inclusion (Fig. 2). Two of the studies are each repeated 
as they included both IMI and UMI participants respec­
tively, resulting in a total of 99 studies included in Table 
2. Relevant data were extracted from the articles and 
summarized in Table 2, including the studied popula­
tion, reported impact of treatment on reproductive out­
comes, evaluation of quality, and risk of bias.
Of the 97 articles collected, 52 (53.6%) were uncon­
trolled (open label) clinical trials, 12 (12.4%) were un­
blinded RCTs and 33 (34.0%) were blinded RCTs. Based 
on the type of antioxidants investigated, 44 (45.4%) of 
the articles tested individual antioxidants, 31 (32.0%) 
tested a combination of several products in variable 
dosages, and 22 (22.7%) used registered antioxidants 
products. Semen parameters were evaluated after an­
tioxidant treatment in 92.8% (n=90 out of 97) of the 
included publications, while the remaining 7 studies 
evaluated markers of sperm function.
Based on the statistical analysis, it is reported that 
85.7% and 89.6% of the low­quality studies showed sig­
nificant improvement (p<0.0001) in semen and sperm 
function parameters, respectively, in infertile men 
after antioxidant supplementation, whereas 65.0% and 
58.3% of the high­quality studies, respectively, reported 
positive effect of antioxidant treatment on semen and 
sperm function parameters (Table 3). However, these 
results were not significant due to the availability of 
a small number of studies in the literature report­
ing semen parameters (n=20) and those reporting 
sperm functions (n=12) and this has led to the under­
powering of statistical analysis. Sample size calculation 
predicted that a total number of 95 and 292 studies 
reporting the outcome of semen parameters and sperm 
functions, respectively, will allow it to gain a statistical 
significance of p<0.05. Furthermore, statistical analysis 
revealed that 78.6% (p=0.0733) and 60% (p=0.6949) of 
low and high­quality studies, respectively, reported a 
positive effect of antioxidant treatment on reproduc­
tive outcomes. However, these values were not signifi­
cant (p≥0.05) due to the availability of very few studies 
(n=14 for low­quality and n=5 for high­quality) in the 
literature. Sample size calculation predicted that a to­
tal number of 33 low and 202 high­quality studies are 
required to attain a statistical significance of p<0.05 
for reproductive outcomes.
1. Varicocele
A total of 11 studies investigated a male population 
affected by varicocele (Table 2). Of those, semen pa­












Non-relevant articles excluded by screening the title,
keywords and abstract (n=1,864)
Non-relevant full-text articles excluded (n=17)
Studies not reporting the included outcomes (n=7)
Non-clinical trials (n=9)
study (n=1)In vitro
Fig. 2. Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses 
(PRISMA) workflow reporting the litera-
ture search strategy.
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in 90.9% (n=10 out of 11) of the included publications. 
Based on these studies, antioxidant supplementation 
seems to be beneficial in varicocele patients as 75.0% 
and 83.0% of low­quality studies, respectively, available 
in the literature, reported positive effect of antioxidant 
treatment on semen and sperm function parameters 
(Table 3). However, these values were not significant. 
Sample size calculation predicted that a total number 
of 41 and 24 studies reporting the outcome of semen 
parameters and sperm function, respectively are need­
ed to reach a statistical significance of p<0.05.
2. Abnormal semen quality
A total of 45 studies investigated a male population 
with abnormal semen quality (Table 2). Of those, semen 
parameters after antioxidant treatment were reported 
in 97.8% (n=44 out of 45) of the included publications, 
whereas sperm function biomarkers were reported in 
25 out of 45 studies (55.6%) (Table 3). The majority of 
the studies showed significant improvement in semen 
and sperm function parameters of men with abnormal 
semen quality after antioxidant supplementation, al­
though these results were not statistically significant 
in case of the high­quality studies (Table 3). Sample 
size calculation predicted that a total number of 204 
studies reporting the outcome of sperm function are 
required to reach a statistical significance of p<0.05.
3. Idiopathic male infertility
A total of 10 studies investigated idiopathic infertile 
men (Table 2). Of those, semen parameters after anti­
oxidant treatment were reported in 90.0% (n=9 out of 
10) of the included publications, whereas sperm function 
biomarkers were reported in 7 out of 10 studies (70.0%) 
(Table 3). Our statistical analysis showed that all the 
high­quality studies reported improvement in the semen 
and sperm function parameters (p<0.0001) after anti­
oxidant treatment in men with IMI. Although a high 
percentage of low­quality studies showed improvement 
in semen and sperm function parameters in men with 
IMI after antioxidant supplementation, these values 
were not significant. Sample size calculation revealed 
that a total number of 24 and 30 studies, respectively, 
reporting the outcome of semen parameters and sperm 
function, may allow to reach statistical significance.
4. Unexplained male infertility
A total of 5 studies investigated the effect of antioxi­
dant therapy in unexplained infertile men (Table 2). 
All of those studies reported semen parameters after 
antioxidant treatment (100%), whereas sperm function 
biomarkers were reported in 4 out of 5 studies (80.0%) 
(Table 3). All the low­quality studies showed improve­
ment in sperm function, while sample size calculation 
predicted that a total number of 41 low­quality studies 
reporting the outcome of semen parameters would allow 
to attain a statistical significance of p<0.05. Further­
Table 3. Number of low and high-quality studies analysing semen parameters and/or sperm function after antioxidant treatment, overall as well 
as in each clinical condition
Group Category
Report of semen parameters Report of sperm function
Number of articles on 
the total of studies
% of studies reporting 
an improvement after 
AOX treatment
Number of articles on 
the total of studies
% of studies reporting 
an improvement after 
AOX treatment
Overall (n=97) Low quality 70/90 (77.8) 85.7*** 50/60 (83.3) 89.6***
High quality 20/90 (22.2) 65.0 12/60 (20.0) 58.3
Varicocele (n=11) Low quality 9/11 (81.8) 75.0 6/11 (54.5) 83.0
High quality 2/11 (18.2) - 0/11 (0) -
Abnormal semen quality (n=45) Low quality 36/44 (81.8) 94.4*** 20/25 (80.0) 90.0**
High quality 8/44 (18.2) 50.0 5/25 (20.0) 60.0
Idiopathic male infertility (n=10) Low quality 6/9 (66.7) 83.0 5/7 (71.4) 80.0
High quality 3/9 (33.3) 100*** 2/7 (28.6) 100***
Unexplained male infertility (n=5) Low quality 4/5 (80.0) 83.3 3/4 (75.0) 100***
High quality 1/5 (20.0) 100*** 1/4 (25.0) 100***
Values are presented as number (%) or percentage only.
AOX: antioxidant, -: not available.





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































more, all the high­quality studies reported a significant 
improvement in the semen and sperm function para­
meters after antioxidant treatment in men with UMI.
5. Analysis of the most recent publications
A total of 21 articles published between January 2019 
and July 2020 investigated the effects of antioxidant 
treatment on semen quality (Table 4) [25,42­46,56,57,92­
101,104,115,121]. Based on our analysis, 13 and 8 studies 
were ranked as low and high­quality, respectively. Of 
these, 19 out of 21 (90.5%) showed improvement in se­
men parameters, while 4 out of 6 (66.7%) reported a 
significant improvement in sperm function. The num­
ber of studies investigating reproductive outcomes af­
ter antioxidant treatment was very limited, with only 
3 out of 5 (60.0%) reporting an improvement in preg­
nancy rate, while birth rate showed no variation in the 
two studies reporting its evaluation.
DISCUSSION
Male infertility is a relatively common concern, con­
tributing significantly to poor reproductive outcomes 
in couples. Oxidative stress has been increasingly iden­
tified as a common mechanism that mediates not only 
the pathophysiology, but also the many etiologies and 
risk factors associated with male infertility [1,2,5,6]. 
Within this context, there is increased use of antioxi­
dants as a therapeutic option in male infertility, how­
ever, there remains no consensus on the efficacy, indi­
cations, dosage or length of treatment [8­11]. Therefore, 
the objective of this study was to systematically review 
the literature of trials investigating antioxidant use in 
male infertility, and to propose some broad guidelines 
for the practicing clinicians based on the currently 
available evidence. The results (Table 2) were stratified 
based on the currently available evidence on the clini­
cal conditions investigated and the data were further 
analysed. Most studies reported men with abnormal 
semen quality (n=45) and infertile men (n=20) as well 
as male infertility conditions such as varicocele (n=11), 
IMI (n=10), UMI (n=5), and urogenital inflammation 
(n=3). Although there is no doubt that assessing sperm 
quality is just a first approach to a diagnosis and that 
evaluation of it as a predictor of fecundity or a couple’s 
fertility success may lead to imprudent conclusions, 
there is no consensus whether the intake of exogenous 
antioxidants should be routinely done in clinical prac­
tice.
Majzoub and Agarwal (2018) [10] performed a sys­
tematic review and identified 26 studies showing posi­
tive effects of exogenous antioxidant intake on sperm 
quality and relevant outcomes of assisted reproduction 
such as live birth rates. The authors critically discussed 
the studies and highlighted that the treatment was 
given only for a short period to a small number of men. 
In addition, the lack of a standardized test to estimate 
oxidative stress levels in sperm and seminal fluid was 
another flaw in these studies, while the heterogeneity 
of the study designs made it particularly challenging 
to compare the effects and reach a robust conclusion. 
This has also been observed in our study, where 60 
studies (61.9%) analyzed a variety of seminal oxidative 
stress markers, including the levels of seminal ROS 
and/or several endogenous antioxidants (i.e., total anti­
oxidant capacity assay, superoxide dismutase, catalase, 
glutathione), markers of lipid peroxidation (i.e., malo­
ndialdehyde), oxidative DNA damage (8­hydroxy­2' ­de­
oxyguanosine), and oxidation­reduction potential (ORP) 
(Table 2). The lack of standardization in the evaluation 
of oxidative stress in seminal fluid before and after 
therapy hinders a definitive conclusion regarding the 
implementation of oral antioxidant supplementation 
for infertile men in the clinical practice. Moreover, the 
lack of detailed methodological descriptions in most 
articles testing oral antioxidants supplementation is a 
major shortcoming that makes comparisons between 
different studies difficult. The evaluation of the length 
of treatment in the analyzed studies also does not help 
in this regard, as it is variable, with 15 (15.5%) studies 
reporting the treatment for an unclear amount of time 
or less than 3 months (Table 2). This might result in 
difficulties to observe any significant influence on hu­
man spermatogenesis.
More recently, a systematic review and meta­
analysis with data from seven RCTs using L­carnitine 
(LC) and L­acetyl carnitine (LAC) as treatment (LC 
2 g/day+LAC 1 g/day in six studies and LC 150 mg/
day+LAC 50 mg/day in one study during 12 or 24 
weeks) enrolling a total of 693 patients, concluded that 
a combined therapy of LC and LAC is effective in men 
with idiopathic oligoasthenoteratozoospermia [122]. 
This conclusion was supported by a significant increase 
in forward sperm motility and total motile sperm 
count. All the other sperm characteristics analyzed 
including semen volume, sperm concentration and per­
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centage of abnormal spermatozoa showed no change. 
Since most of the selected studies lacked consistent and 
detailed information, pregnancy of the female part­
ner as an endpoint was not considered in the analysis. 
Nevertheless, the authors found that the combined 
therapy of LC+LAC could lead to higher pregnancy 
rates. Although this meta­analysis provides evidence 
for a positive effect of dietary supplementation with 
LC+LAC for 3–6 months in men with idiopathic oligo­
asthenoteratozoospermia seeking fertility treatment, 
there are several limitations that hamper a robust 
conclusion. First, the clinical diagnosis of idiopathic 
oligoasthenoteratozoospermia is open to interpretation. 
Thus, each study may have considered and recruited 
distinct types of patients. In addition, since the studies 
had a significant variance regarding the number of se­
lected patients (21 patients in two studies and up to 175 
patients in one study), this impedes the robustness of 
the conclusions. The most striking limitation, common 
to most studies, is the fact that the bioavailability of 
the compounds is unknown. Moreover, the mechanisms 
by which they target testicular function and exert 
their action is not well established and these studies do 
not provide evidence for a synergistic action versus a 
single compound action, nor do they clearly show how 
the compounds act.
CRITICAL EVALUATION OF THE 
NECESSITY OF ADDITIONAL 
DOUBLE-BLIND, RANDOMIZED, 
PLACEBO-CONTROLLED TRIALS
An important issue that must be pointed out in this 
context is that out of 90 studies that reported the ef­
fects of antioxidant treatment on semen parameters, 70 
were low­quality studies, whereas only 20 were ranked 
as high­quality. The overall statistical analysis of both 
low­ and high­quality studies indicates that the antioxi­
dant treatment has a significant positive effect on se­
men parameters. A similar result could still be obtained 
for the effect of the antioxidant treatment on seminal 
oxidative stress and SDF. Only 60 of these studies 
evaluated oxidative stress markers. For the reproduc­
tive outcome, however, only a total of 19 studies, 5 of 
which were of high­quality, have reported this outcome 
parameter. Out of these 5 studies, 3 reported a positive 
effect, while in 2 studies either no effect or a nega­
tive effect was observed. These data clearly indicates 
that the number of high­quality studies is too low to 
obtain significant results. Some of the reasons are that 
fertilization is a multifactorial process. In this case the 
man is treated for oxidative stress, which reflects in 
improvements of semen parameters and seminal oxida­
tive stress, even in high­quality studies. However, when 
looking at fertilization, pregnancy and live birth rates 
oocyte quality has to be considered as a confounding 
variable. These factors are also the reason why the 
number of studies necessary (n=202) to obtain a sig­
nificant result for the high­quality studies is so high 
and is therefore unrealistic. Secondly, the general cost 
for high­quality double­blind, randomized, and placebo­
controlled studies with a sufficiently high number of 
participants is also very high.
Smits et al (2019) [11] performed an extensive meta­
analysis to evaluate if dietary supplementation with 
oral antioxidants was effective and safe. The authors 
analysed 61 studies involving 6,264 subfertile men 
seeking fertility treatment. The authors found that 18 
different oral antioxidants were used in these studies. 
The most relevant conclusion was that oral antioxidant 
supplementation can improve the reproductive capac­
ity of subfertile men and even enhance live birth rates. 
However, the evidence collected was considered of low 
or very low­quality due to serious study limitations, 
making the comparison and/or aggregation to perform 
robust statistical analysis difficult. The studies also 
showed a significant variation in the antioxidant sup­
plementation regimens (type, dose, or even combined 
intake). Some studies used a placebo group to compare 
with, while others chose to compare with no treatment 
or treatment with another antioxidant.
The endpoint for couples attending a fertility treat­
ment has to be clinical pregnancy or live birth, but 
most studies fail to present these data. Only 12 of the 
44 studies that were included in the previously cited 
meta­analysis reported on clinical pregnancy and live 
birth, which is considered a major limitation [11]. The 
latter evidence has also been highlighted in our sys­
tematic analysis of the literature, where only 22 (22.7%) 
and 4 (4.1%) out of 97 studies reported pregnancy and 
live birth rates as a clinical outcome, respectively. 
Pregnancy and live birth are highly influenced by a 
wide variety of embryological and female factors. This 
highlights one of the major problems in literature as 
the studies on the use and effectiveness of antioxidants 
are mostly focused on the males and not on the couple. 
https://doi.org/10.5534/wjmh.200196
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Studies need standardization not only regarding the 
selection of the males, but also the female partners to 
evaluate clinical pregnancy, achievement of live birth, 
and the influence of the treatment. Many confounding 
factors may interfere with such outcomes including 
female age, ovarian reserve, anatomic, inflammatory 
and endocrinal disorders, and as such, the impact of 
any fertility treatment can only be assessed after ad­
justing for such confounding factors. All these factors 
determine the type of ART treatment that is employed, 
namely in vitro fertilization (IVF) or intracytoplasmic 
sperm injection (ICSI), and eventually also have a sig­
nificant impact on the reproductive outcome. Hence, 
the outcomes, positive or negative, can be skewed due 
to numerous confounding factors. Consequently, the fo­
cus of the effectiveness of an antioxidant treatment of 
men should be whether or not the treatment improves 
seminal parameters and sperm function, rather than 
reproductive outcomes which are influenced by numer­
ous other variables that are, i) not/insufficiently con­
sidered in recent studies, and ii) can have a significant 
negative effect on blastulation, embryo development, 
onset/continuation of pregnancy, and live birth. Fur­
thermore, in order to be able to judge the effectiveness 
of treatment, it is necessary to specify the andrological 
condition for which patients are being treated. Without 
this, one might include patients with a condition in a 
study which are not or only poorly responding to the 
treatment. In turn, this would negatively affect the 
outcome of the study.
We have identified 21 studies investigating the ef­
fects of antioxidant treatment on semen quality that 
were published from January 2019 to July 2020. The 
majority of these studies showed an improvement in 
semen parameters and sperm function. With a more 
detailed assessment of quality reported, 13 of the 21 
were ranked as low­quality. Steiner et al [99] and Micic 
et al [94] strictly excluded couples with female factors, 
while most of the studies inadequately documented 
such criteria in their methodologies. From the molecu­
lar point of view, this integrative focus on the couple 
is essential. The sperm­oocyte interaction is sensitive 
to the redox balance, and excessive ROS in spermato­
zoa can lead to impaired oocyte function [123]. Hence, 
the effects of sperm oxidative damage go far beyond 
fertilization since they can have a negative impact on 
embryo development or even pregnancy loss [124,125]. 
On the other hand, the oocyte has the capability to re­
pair damages in spermatozoa [126], and this is another 
unknown variable that needs to be considered when 
thinking of reproductive outcomes as a therapeutic 
effect of treating men with antioxidants. A number 
of critical points can further be pointed out from indi­
vidual studies. Schisterman et al [46] lost 31% of their 
subjects during follow­up and a substantial number of 
couples received non­specified treatment off­site, which 
could alter the study results. The Steiner et al’s [99] 
study was terminated early as they failed to show a 
>10% difference in pregnancy/live birth rates. More­
over, the authors failed to confirm adherence with 
antioxidant treatment, and ovarian stimulation was 
used in couples who did not conceive after 3 months of 
therapy, which could affect the outcomes. Terai et al [98] 
included men between 20 and 60 years of age, which is 
atypical of the reproductive age group. Abstinence was 
defined as 4 or more days without an upper limit [98]. 
Advanced male age and delayed abstinence are associ­
ated with increased oxidative stress measures and with 
alteration in semen parameters [127,128]. Furthermore, 
Terai et al [98] did not include a placebo group, with an 
experimental group investigating a Chinese herbal for­
mula. Hadi et al [45], Alahmar et al [97], Hamidian et 
al [121], Salehi et al [42], Hasoon [43], Gambera et al [93], 
Arafa et al [25], Nazari et al [101], and Jannatifar et al 
[92] all reported improved semen parameters, but these 
studies are uncontrolled open label trials and are rela­
tively underpowered. Furthermore, Alkumait et al [100] 
and Terai et al [98] were unblinded trials with rela­
tively small sample sizes (n=51 and 31, respectively). On 
the other hand, the reviewed studies also have several 
positive virtues that can be pointed out. For example, 
the study by Agarwal et al [129] investigated changes 
in protein expression following antioxidant therapy, 
thereby enhancing our understanding of the physi­
ologic alterations at the molecular level. Several studies 
assessed the effect of antioxidant therapy on SDF lev­
els (Table 2). SDF is increasingly being utilized in the 
evaluation of male factor infertility and is believed to 
be an important determinant of fertility potential [130]. 
Furthermore, SDF is considered as an indirect measure 
of oxidative stress and can validate the benefits of an­
tioxidant therapy in restoring the body’s redox poten­
tial.
Therefore, for the above discussed reasons, having 
more double­blind RCT studies with a large enough 
sample size are neither feasible nor could they provide 
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the expected clear result in terms of improved live 
birth rates after the antioxidant treatment.
STRENGTH WEAKNESS 
OPPORTUNITY THREAT (SWOT) 
ANALYSIS
1. Strengths
Antioxidant supplementation for the treatment of 
male infertility has been increasingly investigated in 
the past decade. Reports suggest that different an­
tioxidant formulations were used to improve sperm 
quality and function in infertile men with various 
clinical circumstances (Table 2). These improvements 
were reflected on reproductive outcomes such as preg­
nancy rate (Table 2). An increasing number of studies 
have investigated the effect of antioxidant therapy on 
measures of oxidative stress, perhaps indicating it is a 
feasible treatment approach/option for patients with 
alteration in seminal redox potential.
2. Weaknesses
The contradictory results in reproductive outcomes 
seen in a number of studies can be considered as the 
main factor limiting the routine use of antioxidants 
for the treatment of male infertility, while female and 
embryological confounding factors were not taken into 
account (Table 2). Yet, in these studies, the male was 
treated with the false expectation that this treatment 
would automatically increase the success of the repro­
ductive outcome. In addition, the low level of evidence 
was extrapolated from the clinical trials reporting 
benefit due to non­homogenous study designs, or in­
consistencies in the treatment regimens (individual or 
combined) used (Table 2). Furthermore, the majority of 
these studies failed to adjust for confounding factors 
(e.g., female factors) that are essential for conception or 
establishment of pregnancy (Table 2).
3. Opportunities
Selection of suitable candidates for antioxidant sup­
plementation by oxidative stress measurement seems a 
logical approach [25]. Indeed, the concept of MOSI has 
been recently proposed. The classification may guide 
the identification of a specific group of idiopathic in­
fertile men who will be more likely to benefit from the 
treatment [2]. Secondly, evaluation of the sperm pro­
teome of idiopathic infertile men before and after oral 
oxidant supplementation offers a window to better un­
derstanding the molecular mechanisms associated with 
sperm function (Fig. 3) [129]. Oral antioxidants may be 
an alternative cost­effective treatment option for infer­
tile couples who desire to avoid assisted reproduction.
4. Threats
Despite the conclusion from Cochrane collaborations 
Fig. 3. Strength Weakness Opportunity
Threat (SWOT) analysis. SWOT has been 
conducted to describe the impact of an-
tioxidant supplementation in the treat-




that oral antioxidant therapy may improve semen pa­
rameters and the likelihood of pregnancy, the lack of 
sufficient high­quality evidence still hinders a consen­
sus among clinicians [11]. In addition, the wide varia­
tion in the treatment regimen raises concerns about 
overzealous use of antioxidants. The detrimental ef­
fects of reductive stress may be as pathological as that 
of oxidative stress [23]. Moreover, the often unpredict­
able outcome after antioxidant supplementation in the 
context of multiple confounding factors in reproduction 
may delay the definitive treatment, particularly for 
couples of advanced age.
CLINICAL GUIDELINES
While antioxidant supplementation is frequently 
utilized for the treatment of male factor infertility, no 
clear recommendations exist endorsing their use for 
specific clinical indications. Therefore, we aimed to de­
velop clinical practice guidelines based on the available 
evidence to help in identifying the clinical circumstanc­
es in which antioxidant supplementation appears to 
be most beneficial. This systematic review included 97 
articles, which investigated antioxidant treatment for 
various etiologies of male infertility. Very few studies 
explored the effect of antioxidants on semen quality of 
men with genitourinary inflammation (n=3), a hyper­
insulinemic state (n=1) and recurrent pregnancy loss in 
female partners (n=1) (Table 2), and are hence insuf­
ficient for evidence­based recommendations for their 
use. On the other hand, there are some perceived high­
quality studies available but, as highlighted above, due 
to the difficulties recruiting a sufficient number of pa­
tients and the small number of these studies, a statisti­
cal analysis will be underpowered and therefore does 
not provide the required answer. As we have shown 
in our analysis, the number of such studies conducted 
under the given circumstances and with a pre­selected 
set of criteria would have to be unreasonably high. 
Yet, looking at the diverse groups of conditions where 
oxidative stress is significantly involved and an anti­
oxidant treatment would make sense, it is clear that in 
absence of prior testing for oxidative stress and with­
out proper identification of suitable patient groups, 
the treatment will fail. Hence, appropriate patient 
identification is essential for the success of the treat­
ment. We were able to formulate recommendations for 
antioxidant treatment for men with abnormal semen 
quality, IMI, UMI, and clinical varicocele based on 
studies reviewed (Table 2). However, it should be noted 
that our recommendations are based on the previously 
published studies, which, in our analysis, cannot be 
considered as high­quality because a number of vari­
ables (such as female factor, inclusion criteria, sample 
size esteem, etc.) were not properly reported. Therefore, 
our recommendation is that antioxidant treatment is 
possible and can result in improved male seminal pa­
rameters if the condition is caused by oxidative stress. 
It is self­evident that the therapy has to be monitored 
to not only avoid over­dosage of antioxidants, but also 
to see if it is successful or if alternative treatments are 
to be considered.
1. Abnormal semen quality
Antioxidants have long been investigated as a thera­
peutic option to counteract the harmful effects of ROS 
toxicity on various body systems. The reproductive sys­
tem is one good example, as seminal oxidative stress is 
believed to be a common pathophysiology and various 
oxidative stress­associated aetiologies can alter sperm 
quality and function. Results of our review demon­
strated that the majority of low­quality studies report­
ed a significant improvement in conventional semen 
parameters and measures of sperm function. However, 
this result was not observed by high­quality studies. 
The recent Cochrane review revealed a somewhat simi­
lar result [11]. While an improvement in conventional 
semen parameters was noted over time, the findings 
were not reliable as a great deal of heterogeneity was 
observed across the included studies. Moreover, antioxi­
dants were found to lower SDF compared to placebo.
Recommendation: antioxidants can improve conven­
tional semen parameters and measures of sperm func­
tion (grade C recommendation).
2. Varicocele
Varicocele is the most common correctable cause of 
male infertility, prevalent in about 40% of men with 
primary infertility and up to 80% of men with second­
ary infertility [131]. Several studies have confirmed the 
presence of higher levels of oxidative stress in infertile 
men with varicocele in comparison to fertile men with 
or without varicocele and infertile men with idiopathic 
infertility [132­136]. This finding may justify the util­
ity of antioxidants as a medical treatment strategy for 
varicocele. Nonetheless, in most patients, varicocelec­
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tomy remains the gold standard modality that results 
in sustained improvement in semen parameters and 
natural conception [137].
Most of the studies exploring the effect of antioxi­
dant supplementation on semen parameters and sperm 
function were of low­quality. While the majority of 
these studies reported an improvement in outcome, the 
evidence supporting antioxidant use as a sole treat­
ment for varicocele is not sufficient. Our sample size 
calculation confirms the need for further research in 
this regard in order to obtain a statistically significant 
effect. However, the reported improvement may be 
clinically relevant supporting antioxidant use as an ad­
junct therapy to varicocele ligation. A recent systematic 
review and meta­analysis explored antioxidant efficacy 
on improving semen quality after varicocelectomy [138]. 
The authors included 6 RCT with 576 patients receiv­
ing various antioxidant regimens or placebo following 
varicocelectomy. Significant improvements in sperm 
concentration (p<0.001), total motility (p=0.03), progres­
sive motility (p<0.001) and normal morphology (p<0.001) 
were reported for the treatment group. However, preg­
nancy rate did not improve (p=0.36). Nonetheless, this 
finding confirms the presence of an additive effect of 
the antioxidant therapy in patients undergoing varico­
celectomy.
Recommendation: antioxidants in addition to varico­
cele ligation result in further improvement in semen 
parameters (grade C recommendation).
3.  Unexplained male infertility and idiopathic 
male infertility
Antioxidants are also commonly utilized for the 
treatment of patients with UMI or IMI. The former is 
defined by failure of conception despite having normal 
semen parameters, while the latter is characterized by 
the presence of semen abnormalities due to unknown 
etiology. The prevalence of UMI and IMI ranges be­
tween 6%–27% and 30%–58%, respectively [3,139]. Oxi­
dative stress is believed to play a significant role in the 
pathophysiology of infertility of unknown origin and 
has been identified in 30%–40% of patients with UMI 
and up to 80% of patients with IMI [140­142].
Our analysis revealed that antioxidant use in men 
with IMI and UMI resulted in significant improve­
ment in semen parameters and sperm function, as 
reported by high­quality studies. While the majority 
of low­quality studies echoed similar improvements, a 
larger number of studies are required to reach statisti­
cal significance.
A systematic review of 32 studies which assessed the 
impact of antioxidant therapy in IMI patients revealed 
an improvement of semen parameters, with the biggest 
benefit observed in sperm motility [143]. Fewer studies 
have assessed antioxidant treatment in patients with 
UMI. A recent study included 29 UMI patients who 
were treated with a combination of antioxidants for 3 
months. The authors reported a significant increase in 
progressive motility (p=0.002), and a decrease in SDF 
(p=0.03) and ORP levels (p=0.02) following treatment. 
Greco et al [117] randomized 64 patients with UMI and 
elevated SDF to either treatment with vitamins C and 
E for 2 months or placebo. While there was no signifi­
cant difference in semen parameter results, significant 
reduction in SDF was noted in the treatment group 
(p<0.001).
Recommendation: antioxidants significantly increase 
sperm quality in men with IMI and UMI (grade B rec­
ommendation).
CURRENT STATE AND FUTURE 
RECOMMENDATIONS FOR 
ANTIOXIDANT RESEARCH
The bivalent action of ROS as essential signaling 
molecules in physiological functions for sperm to fertil­
ize an oocyte [144­146], as well as in mediating a detri­
mental effect on sperm functionality [147­149], suggests 
that appropriate clinical indications for prescribing 
antioxidants and monitoring the treatment are critical 
clinical considerations. Therefore, it is crucial to con­
tinue to study the physiological and pathophysiological 
mechanisms of ROS in the male reproductive tract and 
its relevance for sperm production and conception. In 
this regard, the physiological needs of functional sper­
matozoa, e.g., for the induction of capacitation and ac­
rosome reaction, have to be considered. It appears that 
three aspects of sperm physiology have to be addressed, 
namely i) preservation and support of metabolism, ii) 
improvement of sperm maturation and function, and 
iii) protection against ROS­related trauma. Therefore, 
the correct ratio and concentration of antioxidants is 
essential for this therapeutic effect to occur and any 
new studies must take this into account.
Standardization of oxidative stress measurement 
must also be implemented, not only because a repro­
https://doi.org/10.5534/wjmh.200196
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ducible baseline is needed, but also because many of 
the current studies are either lacking or using differ­
ent oxidative stress measurement and are therefore 
difficult to compare. The assessment of oxidative stress 
may also facilitate the identification of the best candi­
dates and responders to antioxidant therapy (Fig. 4) [2].
Recently, the MiOXSYS system has be proposed as 
a standardized assessment of seminal oxidative stress 
due to its ease of use, cost effectiveness, and repro­
ducibility, as well as proposed evidence based clinical 
guidelines [150,151]. The MiOXSYS system measures 
the overall redox balance in seminal fluid to directly 
evaluate oxidative or reductive stress. Monitoring the 
treatment with antioxidants is another important as­
pect as overtreatment could lead to reductive stress­
related infertility because the little amount of ROS, 
which is essential to trigger physiological functions of 
spermatozoa for it to fertilize oocytes, would be scav­
enged if the antioxidants are overdosed.
For a safe implementation of oral antioxidants use 
in a clinical setting, it is important not only to discover 
the molecular mechanisms of action of the bioactive 
compounds, but also the secondary effects that may 
arise. Personalized or adjusted prescription of oral an­
tioxidants can enhance efficacy, without promoting 
over­dosage and deleterious health effects. Methodol­
ogy and couple selection must be well reported. Doses 
and duration of the treatment should be adjusted ac­
cording to several factors including the detected levels 
of ROS and antioxidant enzymes in seminal fluid and 
spermatozoa. Bioavailability of the compounds and 
their mechanism of action should also be thoroughly 
studied. More time­points to detect the oxidative bal­
ance of spermatozoa and seminal fluid should also be 
considered. Finally, one should not only look at the 
oral antioxidant therapy as a clinical treatment of the 
male and then expect that this treatment will result 
in the live birth of a healthy baby, but rather consider 
reproduction as a joint responsibility of both partners 
where a male and a female equally contribute to the 
reproductive outcome. Currently, the female partner is 
not examined for possible oxidative stress, but there is 
also a lack of knowledge about the impact of ROS and 
the redox level (oxidative and reductive stress) in the 
female reproductive system on oocyte development and 
maturation as well as on embryo development. A study 
by Ufer et al (2010) [152] indicated that proper embryo 
development depends on finely tuned redox control. On 
the other hand, elevated levels of antioxidants may re­
sult in teratogenic developments [153].
Currently, there is significant heterogeneity in tri­
als reporting antioxidants on male infertility. This 
includes the condition investigated, type of antioxidant 
used, duration of the study, and the outcomes mea­
sured (Table 2). Furthermore, it is essential to select 
previously studied antioxidant candidates as well as 
new potential compounds, and also determine if they 






























Fig. 4. Treatment options for male oxida-
tive stress infertility (MOSI). OS: oxidative 
stress, ORP: oxidation-reduction poten-
tial, MAGI: male accessory gland infec-
tion.
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as has been shown in some studies [154]. Due to several 
factors, including the high costs and the high number 
of participants needed to reach a statistically robust 
study, the individuals recruited in any new study must 
be well selected based on strict inclusion/exclusion cri­
teria. This means the patients should have the same 
infertility diagnosis and similar semen analysis: for 
example, mixing patients with azoospermia, mild oli­
gozoospermia or asthenozoospermia should be avoided. 
Meeting these criteria will likely be difficult at a 
single institution and does not even include recruiting 
patients for an adequate control group. Use of placebo 
in the control group is also mandatory to avoid bias. 
Notably, confounding factors, including dietary habits, 
are often overlooked in most RCTs, but when patients 
are being enrolled in a study with antioxidant supple­
mentation, baseline antioxidant intake and diet should 
be evaluated in both partners, male and female. Fur­
thermore, an appropriate primary outcome, such as de­
crease in oxidative stress or SDF, should also be evalu­
ated. Finally, it is critical to set a correct time period 
for the study. A short to medium time period of 3 to 6 
months is considered ideal to study the antioxidant ef­
fects on semen parameters.
UNRESOLVED QUESTIONS
What makes the situation even more complicated is 
that there are no dose­response studies in humans to 
pinpoint the optimum antioxidant dosages needed to 
produce improvement in semen quality. We also still do 
not know the normal physiological range of the redox 
levels in both males and females. For spermatozoa, a 
recent study by Panner Selvam et al (2020) [24] indicat­
ed normal redox values between ­9.76 and 1.48 mV/106 
sperm/mL. Although these values already indicate 
oxidative or reductive stress conditions, the normal 
physiological range will be much narrowed in between 
these values. In the female, one might have to consider 
variations depending on the menstrual cycle and/or the 
onset of pregnancy. Besides, these values might change 
with age and/or health status. Furthermore, the effec­
tive bioavailability of antioxidants in the testes, the 
epididymis and the semen is still unknown. Since many 
antioxidants (e.g., co­enzyme Q10, vitamin E, and carni­
tines) can easily cross the blood­testis barrier, a proper 
balance for the redox level has to be achieved because 
an over­dosage might lead to reductive stress, which 
has been shown to be as harmful as oxidative stress [22].
CONCLUSIONS
This systematic review identified a significant num­
ber of well­designed studies that unequivocally show 
the beneficial effects of oral antioxidants in improving 
semen parameters and pregnancy outcome. However, 
despite the safety and efficacy of  the antioxidant 
therapy, five main factors have hindered its wide ac­
ceptance and implementation in the treatment of male 
infertility: i) lack of randomized placebo­controlled 
studies that show the safety and efficacy of antioxi­
dants in improving pregnancy rates in infertile couples; 
ii) type of antioxidant to be used; iii) dose; iv) duration 
of treatment; and v) costs. 
Although randomized placebo­controlled studies 
are regarded as the gold standard in the validation 
of the safety and efficacy of therapies, given the fact 
that the occurrence of a pregnancy is a multifactorial 
process mainly determined by the genomic quality of 
the egg, to show the impact of antioxidant therapy on 
pregnancy outcome in randomized placebo­controlled 
studies would be unrealistic and extremely difficult to 
perform. Given the difficulty in carrying out these ran­
domized placebo­controlled studies and the existence 
of significant clinical evidence supporting the safety 
and efficacy of antioxidants in improving pregnancy 
outcome in infertile couples, the use of antioxidant 
therapy should be recommended.
To answer the question of what type of antioxidant 
should be used, we believe that antioxidants that read­
ily cross the blood­testis and blood­epididymis barriers 
should be recommended. The formulation should be 
well­balanced as lipid­soluble and water­soluble antiox­
idants together with other factors are closely interact­
ing, thereby regenerating lipid­located antioxidants. If 
this balance is not given, it may not only result in sub­
optimal antioxidant effects, but also in paradoxical pro­
oxidant effects due to interference in redox reactions.
Concerning the dose to be used, the dose should be 
high enough to restore the normal physiological cel­
lular functions by reducing oxidative stress without 
compromising the physiological role of ROS in sperm 
maturation and fertilization reactions. An overdosage 
which may lead to reductive stress should be avoided.
The duration of an antioxidant therapy would have 
to be adjusted according to the place where the damage 
https://doi.org/10.5534/wjmh.200196
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occurs. If it is in the epididymis, a treatment course of 
at least two weeks should be sufficient to counteract 
ROS­induced damage. In addition, since oxidative stress 
in the epididymis is a constitutive process and antioxi­
dants have no side­effects, antioxidant therapy should 
be recommended until pregnancy is achieved. This 
would apply to couples undergoing timed intercourse as 
well as to couples undergoing in vitro fertilization. On 
the other hand, if the oxidative damage is occurring in 
the testes such as in the case of clinical varicocele, the 
duration of antioxidant treatment should be of at least 
three months.
Finally, the cost argument has to be seen from the 
perspective of the sponsors of high quality randomized, 
double­blind placebo­controlled clinical trials. Natural 
antioxidant formulations have very low cost, and their 
use would be amply justified based on efficacy and 
safety as well as for cost­saving aspects for patients 
and health systems. The problem for the possible fund­
ing by the pharmaceutical industry of the studies is to 
recover the high costs of a trial on a cheap antioxidant, 
which can be available over the counter, and for which 
not even intellectual property rights are available.
In conclusion, the use of antioxidants that readily 
cross the blood­testis and blood­epididymis barriers 
should be recommended. Their efficacy, lack of side­
effects and low costs should encourage their wider ac­
ceptance and implementation among infertility special­
ists for their use in the treatment of male infertility 
and infertile couples. Despite these favorable aspects of 
antioxidant treatments for idiopathic and UMI, more 
high­quality research is needed to understand the ef­
fects of ROS and antioxidants on the human fertilizing 
potential in both male and female. However, the practi­
cality of conducting such studies remains questionable.
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